Analysts Conflicted on These Healthcare Names: Bristol-Myers Squibb (BMY) and Envista Holdings (NVST)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bristol-Myers Squibb (BMY – Research Report) and Envista ...
Investor's Business Daily on MSN3h
Bristol Myers Squibb Trying To Close In On Key Technical Measure
In a welcome move, Bristol Myers Squibb saw its Relative Strength Rating improve from 70 to 76 on Tuesday. Please watch the video at Investors.com - Stock Market Exposure: How To Make Incremental ...
Business Insider18h
Bristol-Myers Squibb: Hold Rating Maintained Amid Positive Clinical Trials and Long-term EPS Concerns
David Risinger, an analyst from Leerink Partners, maintained the Hold rating on Bristol-Myers Squibb (BMY – Research Report). The associated price target was raised to $55.00. David Risinger has given ...
Insider Monkey1d
Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy Right Now?
In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE ... CEO of the Alliance for ...
Bristol Myers earnings beat expectations, driven by sales of older drugs
By Michael Erman (Reuters) -Bristol Myers Squibb reported a higher-than-expected third-quarter profit on Thursday, citing ...